Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents-Reference-Cited by-同舟云学术

Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents

Published:2024 Issue:6 Volume:15 Page:2114-2126
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Wang Zhen¹^ORCID,Zhang Juan¹,Gai Conghao²^ORCID,Wang Jing²,Zhuo Xiaobin²,Song Yan³,Zou Yan²,Zhang Peichao²,Hou Guige⁴^ORCID,Meng Qingguo¹,Zhao Qingjie²,Chai Xiaoyun²^ORCID

Affiliation:

1. School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai 264005, China

2. Department of Organic Chemistry, School of Pharmacy, Naval Medical University, Shanghai 200433, China

3. Navy Medical Center, Naval Medical University, Shanghai 200433, China

4. School of Pharmacy, Binzhou Medical University, Yantai 264003, China

Abstract

Compound 10h, a novel dibenzylbutane lignan LCA derivative, has potential anti-inflammatory activity by inhibiting NF-κB activation.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MD/D4MD00053F

Reference39 articles.

1. Inflammation in Focus: The Beginning and the End

2. Susceptibility to chronic inflammation: an update

3. Role of Antioxidants and Natural Products in Inflammation

4. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

5. Nonresolving Inflammation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of the dibenzylbutane lignan LCA derivatives and evaluation of their anti-inflammatory activities;2024-08-22

2. Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents;RSC Medicinal Chemistry;2024